Analgesia Nociception Index-guided Anesthesia and Standard Anesthesia
Not Applicable
Not yet recruiting
- Conditions
- Gastric Cancer
- Registration Number
- NCT06123637
- Lead Sponsor
- Ajou University School of Medicine
- Brief Summary
The primary purpose of this study is to compare the analgesia nociception index-guided anesthesia and standard anesthesia on remifentanil requirement in desflurane anesthesia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
- Clinical diagnosis of gastric cancer
Exclusion Criteria
- Conversion to open laparotomy
- Prior opioid abuse
- Prior infection
- Cardiac arrythmia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Remifentanil requirement at time of the end of skin suture (up to 4 hours) Assessing the total dose of remifentanil administered from skin incision until skin suture
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the analgesia nociception index in gastric cancer surgery?
How does ANI-guided anesthesia compare to standard protocols in remifentanil dosing for gastric cancer patients?
Are there specific biomarkers that predict response to desflurane-based anesthesia in gastric cancer?
What adverse events are associated with remifentanil use in desflurane anesthesia for gastric cancer surgery?
What combination therapies are being explored with desflurane and remifentanil in gastric cancer anesthesia?